Indivior Pharmaceuticals, Inc. INDV Purchases of fixed maturity securities
Purchases of fixed maturity securities at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireHeldToMaturitySecurities.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities?
- Indivior Pharmaceuticals, Inc. (INDV) reported purchases of fixed maturity securities of $5M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's purchases of fixed maturity securities has grown at a -56.6% compound annual growth rate (CAGR), from $245M to $20M.
- What does purchases of fixed maturity securities mean?
- Cash spent purchasing fixed-income securities (bonds, notes, debentures) for the investment portfolio.